drugset / Trial / NCT01928862

Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for Colonoscopy

NCT01928862

Phase 1/2 Completed 78 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupSingle-blindTreatment

Summary

To study the efficacy and safety of Prepopik® in children aged 9 to 16 years for overall colon cleansing in preparation of colonoscopy

Timeline

Start
2014-06-03
Primary completion
2017-02-15
Completion
2017-03-16

Drugs

EvaluationDrugModalityDoseRoute
Subject PICOPREP Small molecule
Comparator polyethylene glycol Other / unclassified Oral

Indications

No indication recorded.